DRGEM CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10,220 KRW | +2.30% |
|
+5.36% | -1.83% |
| 2023 | DRGEM Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | DRGEM Corporation's Equity Buyback announced on November 2, 2021, has expired. | CI |
| Sales 2022 | 110B 79.54M 6.37B | Sales 2023 | 113B 81.53M 6.53B | Capitalization | 115B 82.8M 6.63B |
|---|---|---|---|---|---|
| Net income 2022 | 14.39B 10.39M 833M | Net income 2023 | 9.19B 6.64M 532M | EV / Sales 2022 | 1.03 x |
| Net cash position 2022 | 3.16B 2.28M 183M | Net cash position 2023 | 2.96B 2.14M 171M | EV / Sales 2023 | 0.99 x |
| P/E ratio 2022 |
8.12
x | P/E ratio 2023 |
12.5
x | Employees | 235 |
| Yield 2022 |
2.99% | Yield 2023 |
-
| Free-Float | 42.22% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.30% | ||
| 1 week | +5.36% | ||
| Current month | +0.59% | ||
| 1 month | +0.59% | ||
| 3 months | -5.37% | ||
| 6 months | -3.86% | ||
| Current year | -1.83% |
1 week
9 600.00
10 330.00
1 month
9 600.0010 330.00
Current year
9 600.0011 310.00
1 year
9 600.0012 600.00
3 years
7 710.0015 850.00
5 years
4 600.0025 850.00
10 years
4 600.0025 850.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jung-Byung Park
CEO | Chief Executive Officer | 61 | - |
Young-Min Seo
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Byung-Il Hwang
BRD | Director/Board Member | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jung-Byung Park
CEO | Chief Executive Officer | 61 | - |
Min-Soo Byun
BRD | Director/Board Member | 51 | - |
Byung-Il Hwang
BRD | Director/Board Member | 58 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 10,220 | +2.30% | 21,459 |
| 29/04/24 | 9,990 | +0.30% | 11,701 |
| 26/04/24 | 9,960 | +1.22% | 5,208 |
| 25/04/24 | 9,840 | +0.10% | 2,235 |
| 24/04/24 | 9,830 | +1.65% | 4,465 |
End-of-day quote Korea S.E., April 29, 2024
More quotes
DRGEM CORPORATION is a Korea-based company mainly engaged in the manufacturing and distribution of diagnostic X-ray systems. The Company manufactures and sells diagnostic analog X-ray systems, diagnostic digital X-ray systems, diagnostic retrofit X-ray systems, as well as components of X-ray systems. The Companyâs main products include diagnostic x-ray systems, high voltage X-ray generators, digital upgrade systems, mobile x-ray systems, veterinary digital radiography systems, among others. The Company distributes its products within domestic and into overseas markets.
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -1.83% | 81.35M | |
| -3.25% | 15.01B | |
| -38.91% | 2.8B | |
| -12.68% | 2.45B | |
| -12.18% | 1.46B | |
| -.--% | 1.12B | |
| +43.80% | 518M | |
| +92.56% | 505M | |
| +14.23% | 245M | |
| -19.37% | 183M |
- Stock Market
- Equities
- A263690 Stock
